Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05082259
Title ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (ASTEROID)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Age Groups: adult | senior
Covered Countries

No variant requirements are available.